GOSS

Conviction 14Scan · Mon, Aug 10, 2026

GOSS$0.1738-2.36%

ResistanceSupportVol 14

Vol MA14 54.99M

May 11May 28Jun 16Jul 6Jul 23Aug 10

WSB mentions · 24h changelatest -40.00%· 3 mentions

May 11May 28Jun 16Jul 6Jul 23Aug 10

Gossamer Bio, Inc.Pharmaceutical Preparationswww.gossamerbio.com ↗

Price0.1738

Change-2.36%

Gap+0.45%

Rel volume0.30×

Avg volume45.84M

Avg $ vol8.58M

SMA 200.1692

SMA 500.1717

SMA 2001.32

Price vs 50+1.25%

Price vs 200-86.87%

MA stackmixed

50/200 cross—

Supertrendup · 0.1360

RSI (14)49

MACD hist0.00

MACD cross—

Stoch %K / %D31 / 33

ADX (14)23

+DI / −DI28 / 19

RSI divergence—

MACD divergence—

ATR %+13.00%

ADR %14.58%

52w high3.79

52w low0.1360

From 52w high-95.41%

Above 52w low+27.79%

New 52w highNo

SqueezeOff

Bollinger width48.59%

%B0.56

Donchian pos38.86%

Donchian high0.2682

Donchian low0.1138

AVWAP (52w high)0.4904

vs AVWAP high-64.56%

AVWAP (52w low)0.1853

vs AVWAP low-6.20%

OBV trendUp

Chaikin MF (20)0.15

Today vs 20d0.30×

Avg vol (14d)54.99M

Avg vol (20d)45.84M

Avg $ vol (20d)8.58M

Market cap—

RS 3m (vs SPY)-53.91%

RS 6m (vs SPY)-106.80%

RS line new highNo

Trend template1/8

Technical rank24.4

1 week+0.12%

1 month+2.42%

3 months-46.85%

6 months-92.31%

1 year-90.01%

YTD-93.97%

P/E-0.25

P/B-0.26

P/S0.86

P/FCF-0.24

EPS-0.7500

Div yield—

ROE105.50%

ROA-132.17%

Debt/Eq0.00

Current2.20

EV/EBITDA-0.00

Gross margin—

Net margin-351.49%

Rev growth-57.74%

EPS growth-201.39%

Price target1.07

Target upside499.78%

Analyst ratingBuy

Institutional45.50%

Ent. value841.82K

Revenue16.95M

Net income-46.66M

Gross profit—

Free cash flow-171.34M

IndustryPharmaceutical Preparations

ExchangeNasdaq

Shares out488.85M

Employees162

ListedFri, Feb 8, 2019

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction14 / 100

Pattern quality—

Tech rank24.4 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.2340

Support0.1230

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in GOSS

All disclosures →

No recent disclosed trades by Congress in GOSS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in GOSS · 6 buys

Insider	Side	Shares	Value	Traded	Filed
Quisel John D Director · Stock Option (Right to Buy) · 2026-06-04	Grant	115K	$0	2026-06-04	2026-06-05
Drynan Skye Director · Stock Option (Right to Buy) · 2026-06-04	Grant	115K	$0	2026-06-04	2026-06-05
Daniel Thomas O Director · Stock Option (Right to Buy) · 2026-06-04	Grant	115K	$0	2026-06-04	2026-06-05
Milligan Sandra Director · Stock Option (Right to Buy) · 2026-06-04	Grant	115K	$0	2026-06-04	2026-06-05
Nathan Steven D Director · Stock Option (Right to Buy) · 2026-06-04	Grant	115K	$0	2026-06-04	2026-06-05
Cox Russell J. Director · Stock Option (Right to Buy) · 2026-06-04	Grant	115K	$0	2026-06-04	2026-06-05

SEC filings

EDGAR filings in GOSS · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.